The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses
Open accessAbstract
The neuronal ceroid lipofuscinoses (NCLs) are clinically and genetically heterogeneous neurodegenerative disorders. Most are autosomal recessively inherited. Clinical features include a variable age of onset, motor and mental decline, epilepsy, visual loss, and premature death. Mutations in eight genes (PPT1/CLN1, TPP1/CLN2, CLN3, CLN5, CLN6, MFSD8/CLN7, CLN8) have been identified and several more are predicted to exist, including two provisionally named CLN4 and CLN9. Despite excessive in vitro and in vivo studies, the precise functions of the NCL proteins and the disease mechanisms remain elusive. To date 365 NCL-causing mutations are known, with 91 novel disease-causing mutations reported. These are reviewed with an emphasis on their complex correlation to phenotypes. Different mutations within the NCL spectrum can cause variable disease severity. The NCLs exemplify both phenotypic convergence or mimicry and phenotypic divergence. For example, mutations in CLN5, CLN6, MFSD8, or CLN8 can underlie the clinically similar late infantile variant NCL disease. Phenotypic divergence is exemplified by different CLN8 mutations giving rise to two very different diseases, the mild CLN8 disease, EPMR (progressive epilepsy with mental retardation), and the more severe CLN8 disease, late infantile variant. The increase in the genetic understanding of the NCLs has led to improved diagnostic approaches, and the recent proposal of a new nomenclature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
Dunnen, J. T. D., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n · Cited by 1,756
[13] Evolutionary families of metallopeptidases
Rawlings, N. D., & Barrett, A. J. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)48015-3 · Cited by 806
Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., & Peltonen, L. (1995) · Nature · doi:10.1038/376584a0 · Cited by 737
Isolation of a novel gene underlying batten disease, CLN3
Lerner, T. J., Boustany, R.-M. N., Anderson, J. W., D'Arigo, K. L., Schlumpf, K., Buckler, A. J., Gusella, J. F., & Haines, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90274-0 · Cited by 601
Sleat, D. E., Donnelly, R. J., Lackland, H., Liu, C.-G., Sohar, I., Pullarkat, R. K., & Lobel, P. (1997) · Science · doi:10.1126/science.277.5333.1802 · Cited by 581
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Siintola, E. (2006) · Brain · doi:10.1093/brain/awl107 · Cited by 389
Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras.
Camp, L. A., & Hofmann, S. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41567-0 · Cited by 361
Mitochondrial ATP synthase subunit c storage in the ceroid‐lipofuscinoses (Batten disease)
Palmer, D. N., Fearnley, I. M., Walker, J. E., Hall, N. A., Lake, B. D., Wolfe, L. S., Haltia, M., Martinus, R. D., & Jolly, R. D. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320420428 · Cited by 361
The Neuronal Ceroid-Lipofuscinoses
Haltia, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.1 · Cited by 353
Neuronal ceroid lipofuscinoses
Jalanko, A., & Braulke, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.004 · Cited by 339
Cloning and sequence analysis of cDNA for human cathepsin D.
Faust, P. L., Kornfeld, S., & Chirgwin, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4910 · Cited by 322
Ranta, S., Zhang, Y., Ross, B., Lonka, L., Takkunen, E., Messer, A., Sharp, J., Wheeler, R., Kusumi, K., Mole, S., et al. (1999) · Nature Genetics · doi:10.1038/13868 · Cited by 319
Self-citationNeuronal ceroid-lipofuscinoses in childhood
Santavuori, P. (1988) · Brain and Development · doi:10.1016/s0387-7604(88)80075-5 · Cited by 313
Mole, S. E., Williams, R. E., & Goebel, H. H. (2005) · Neurogenetics · doi:10.1007/s10048-005-0218-3 · Cited by 307
Self-citationSavukoski, M., Klockars, T., Holmberg, V., Santavuori, P., Lander, E. S., & Peltonen, L. (1998) · Nature Genetics · doi:10.1038/975 · Cited by 302
Cathepsin D Deficiency Is Associated with a Human Neurodegenerative Disorder
Steinfeld, R., Reinhardt, K., Schreiber, K., Hillebrand, M., Kraetzner, R., Brück, W., Saftig, P., & Gärtner, J. (2006) · The American Journal of Human Genetics · doi:10.1086/504159 · Cited by 302
Lysosomal Targeting of Palmitoyl-protein Thioesterase
Verkruyse, L. A., & Hofmann, S. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15831 · Cited by 259
Autophagy Is Disrupted in a Knock-in Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
Cao, Y., Espinola, J. A., Fossale, E., Massey, A. C., Cuervo, A. M., MacDonald, M. E., & Cotman, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602180200 · Cited by 256
Tyynelä, J., Sohar, I., Sleat, D. E., Gin, R. M., Donnelly, R. J., Baumann, M., Haltia, M., & Lobel, P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2786 · Cited by 245
The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter
Siintola, E., Topcu, M., Aula, N., Lohi, H., Minassian, B. A., Paterson, A. D., Liu, X.-Q., Wilson, C., Lahtinen, U., Anttonen, A.-K., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518902 · Cited by 229
Self-citationCathepsin D: A cellular roadmap
Zaidi, N., Maurer, A., Nieke, S., & Kalbacher, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.099 · Cited by 224
Gao, H., Boustany, R.-M. N., Espinola, J. A., Cotman, S. L., Srinidhi, L., Antonellis, K. A., Gillis, T., Qin, X., Liu, S., Donahue, L. R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338190 · Cited by 220
Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs)
Holopainen, J. M., Saarikoski, J., Kinnunen, P. K. J., & Järvelä, I. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02530.x · Cited by 211
Spectrum of Mutations in the Batten Disease Gene, CLN3
Munroe, P. B., Mitchison, H. M., O'Rawe, A. M., Anderson, J. W., Boustany, R.-M., Lerner, T. J., Taschner, P. E. M., Vos, N. D., Breuning, M. H., Gardiner, R. M., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514846 · Cited by 205
Self-citationWheeler, R. B., Sharp, J. D., Schultz, R. A., Joslin, J. M., Williams, R. E., & Mole, S. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338708 · Cited by 199
Self-citationLysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6
Poët, M., Kornak, U., Schweizer, M., Zdebik, A. A., Scheel, O., Hoelter, S., Wurst, W., Schmitt, A., Fuhrmann, J. C., Planells-Cases, R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606137103 · Cited by 199
Self-citationSharp, J. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.591 · Cited by 190
Hellsten, E., Vesa, J., Olkkonen, V. M., Jalanko, A., & Peltonen, L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00909.x · Cited by 187
TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?
Winter, E., & Ponting, C. P. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02154-0 · Cited by 181 · cited 2×
“The TLC domain in CLN8 is composed of the residues p.62-262 [Winter and Ponting, 2002].”
BackgroundSleat, D. E., Gin, R. M., Sohar, I., Wisniewski, K., Sklower-Brooks, S., Pullarkat, R. K., Palmer, D. N., Lerner, T. J., Boustany, R.-M., Uldall, P., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302427 · Cited by 178
Steinfeld, R., Heim, P., von Gregory, H., Meyer, K., Ullrich, K., Goebel, H. H., & Kohlschütter, A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10660 · Cited by 178
Bellizzi, J. J., Widom, J., Kemp, C., Lu, J.-Y., Das, A. K., Hofmann, S. L., & Clardy, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080508097 · Cited by 167
Hall, N. A., Lake, B. D., Dewji, N. N., & Patrick, A. D. (1991) · Biochemical Journal · doi:10.1042/bj2750269 · Cited by 166
Kufs Disease, the Major Adult Form of Neuronal Ceroid Lipofuscinosis, Caused by Mutations in CLN6
Arsov, T., Smith, K. R., Damiano, J., Franceschetti, S., Canafoglia, L., Bromhead, C. J., Andermann, E., Vears, D. F., Cossette, P., Rajagopalan, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.004 · Cited by 164
Self-citationTwo crystal structures for cathepsin D: the lysosomal targeting signal and active site.
Metcalf, P., & Fusek, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05774.x · Cited by 163
Luiro, K., Yliannala, K., Ahtiainen, L., Maunu, H., Järvelä, I., Kyttälä, A., & Jalanko, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh321 · Cited by 161
Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S.
Das, A. K., Becerra, C., Yi, W., Lu, J. Y., Siakotos, A. N., Wisniewski, K. E., & Hofmann, S. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3112 · Cited by 156
Fearnley, I. M., Walker, J. E., Martinus, R. D., Jolly, R. D., Kirkland, K. B., Shaw, G. J., & Palmer, D. N. (1990) · Biochemical Journal · doi:10.1042/bj2680751 · Cited by 154
Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome
Scott, H. S., Blanch, L. C., Guo, X.-H., Freeman, C. G., Orsborn, A., Baker, E. G., Sutherland, G. R., Morris, C. P., & Hopwood, J. J. (1995) · Nature Genetics · doi:10.1038/ng1295-465 · Cited by 151
Elleder, M., Sokolová, J., & Hřebíček, M. (1997) · Acta Neuropathologica · doi:10.1007/s004010050629 · Cited by 145
Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis
Kousi, M., Siintola, E., Dvořáková, L., Vlášková, H., Turnbull, J., Topçu, M., Yüksel, D., Gökben, S., Minassian, B. A., Elleder, M., et al. (2009) · Brain · doi:10.1093/brain/awn366 · Cited by 144
Self-citationMitchison, H. M., Hofmann, S. L., Becerra, C. H., Munroe, P. B., Lake, B. D., Crow, Y. J., Stephenson, J. B., Williams, R. E., Hofman, I. L., Taschner, P. E., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.291 · Cited by 136
Self-citationInfantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1
Järvelä, I. E., Schleutker, J., Haataja, L. M., Santavuori, P., Puhakka, L., Manninen, T., Palotie, A. V., Sandkuijl, L. A., Renlund, M., White, R. L., et al. (1991) · Genomics · doi:10.1016/0888-7543(91)90235-7 · Cited by 133
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein
Isosomppi, J., Vesa, J., Jalanko, A., & Peltonen, L. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.8.885 · Cited by 131
Vesa, J., Chin, M. H., Oelgeschläger, K., Isosomppi, J., Dell’Angelica, E. C., Jalanko, A., & Peltonen, L. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0031 · Cited by 124
Kyttälä, A., Ihrke, G., Vesa, J., Schell, M. J., & Luzio, J. P. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0120 · Cited by 123
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
Lonka, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1691 · Cited by 122
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
Järvelä, I. E. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.6.1091 · Cited by 120
CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein
Mole, S., Michaux, G., Codlin, S., Wheeler, R. B., Sharp, J. D., & Cutler, D. F. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.042 · Cited by 119
Self-citationA Variant of Jansky-Bielschowsky Disease
Santavuori, P., Rapola, J., Sainio, K., & Raitta, C. (1982) · Neuropediatrics · doi:10.1055/s-2008-1059612 · Cited by 118
Cooper, J. D., Russell, C., & Mitchison, H. M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.08.002 · Cited by 113
CLN3, the protein associated with batten disease: Structure, function and localization
Phillips, S. N., Benedict, J. W., Weimer, J. M., & Pearce, D. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20367 · Cited by 111
Apoptosis as the Mechanism of Neurodegeneration in Batten's Disease
Lane, S. C., Jolly, R. D., Schmechel, D. E., Alroy, J., & Boustany, R. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020677.x · Cited by 107
The Spectrum of Jansky-Bielschowsky Disease
Santavuori, P., Rapola, J., Nuutila, A., Raininko, R., Lappi, M., Launes, J., Herva, R., & Sainio, K. (1991) · Neuropediatrics · doi:10.1055/s-2008-1071423 · Cited by 104
Ranta, S., Topçu, M., Tegelberg, S., Tan, H., Üstübütün, A., Saatçi, I., Dufke, A., Enders, H., Pohl, K., Alembik, Y., et al. (2004) · Human Mutation · doi:10.1002/humu.20018 · Cited by 101
Self-citationThe occurrence in proteins of the tripeptides Asn-X-Ser and Asn-X-Thr and of bound carbohydrate
Hunt, L. T., & Dayhoff, M. O. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90270-6 · Cited by 98
Heine, C., Koch, B., Storch, S., Kohlschütter, A., Palmer, D. N., & Braulke, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400643200 · Cited by 96
Lyly, A., von Schantz, C., Heine, C., Schmiedt, M.-L., Sipilä, T., Jalanko, A., & Kyttälä, A. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-83 · Cited by 96
Northern Epilepsy: A Novel Form of Neuronal Ceroid‐Lipofuscinosis
Herva, R., Tyynelä, J., Hirvasniemi, A., Syrjäkallio‐Ylitalo, M., & Haltia, M. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00255.x · Cited by 95
Batten disease: evaluation of CLN3 mutations on protein localization and function
Haskell, R. E. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.735 · Cited by 95
Purification and characterisation of a tripeptidyl aminopeptidase I from rat spleen
Vines, D. J., & Warburton, M. J. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(98)00012-0 · Cited by 94
Lauronen, L., Munroe, P. B., Järvelä, I. E., Autti, T. H., Mitchison, H. M., O'Rawe, A., Gardiner, R. M., Mole, S., Puranen, J., Häkkinen, A. ‐., et al. (1999) · Neurology · doi:10.1212/wnl.52.2.360 · Cited by 91
Self-citationHirvasniemi, A., Lang, H. N., Lehesjoki, A., & Leisti, J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.3.177 · Cited by 91
Self-citationTopçu, M., Tan, H., Yalnızoğlu, D., Usubutün, A., Saatçi, I., Aynaci, M., Anlar, B., Topaloğlu, H., Turanlı, G., Köse, G., et al. (2004) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2004.2761 · Cited by 89
Ezaki, J., Takeda‐Ezaki, M., Koike, M., Ohsawa, Y., Taka, H., Mineki, R., Murayama, K., Uchiyama, Y., Ueno, T., & Kominami, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02132.x · Cited by 88
Kitzmüller, C., Haines, R. L., Codlin, S., Cutler, D. F., & Mole, S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm306 · Cited by 88
Self-citationSohár, I., Sleat, D. E., Jadot, M., & Lobel, P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730700.x · Cited by 87
A CONGENITAL FORM OF AMAUROTIC FAMILY IDIOCY
Norman, R. M., & Wood, N. (1941) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.4.3-4.175 · Cited by 86
Identification of novel lysosomal matrix proteins by proteome analysis
Kollmann, K., Mutenda, K. E., Balleininger, M., Eckermann, E., FIGURA, K. V., Schmidt, B., & Lübke, T. (2005) · PROTEOMICS · doi:10.1002/pmic.200401247 · Cited by 84
Molecular genetics of the NCLs — status and perspectives
Siintola, E., Lehesjoki, A., & Mole, S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.006 · Cited by 84
Self-citationTahvanainen, E., Ranta, S., Hirvasniemi, A., Karila, E., Leisti, J., Sistonen, P., Weissenbach, J., Lehesjoki, A., & de la Chapelle, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7267 · Cited by 83
Self-citationThe clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland
Moore, S., Buckley, D., MacMillan, A., Marshall, H. D., Steele, L., Ray, P., Nawaz, Z., Baskin, B., Frecker, M. F., Carr, S., et al. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01054.x · Cited by 83
Phenotype–genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5)
Holmberg, V., Lauronen, L., Autti, T. H., Santavuori, P., Savukoski, M., Uvebrant, P., Hofman, I. L., Peltonen, L., & Järvelä, I. E. (2000) · Neurology · doi:10.1212/wnl.55.4.579 · Cited by 82
Spectrum ofCLN6mutations in variant late infantile neuronal ceroid lipofuscinosis
Sharp, J. D., Wheeler, R. B., Parker, K. A., Gardiner, R. M., Williams, R. E., & Mole, S. (2003) · Human Mutation · doi:10.1002/humu.10227 · Cited by 81
Self-citationNovel mutation and the first prenatal screening of cathepsin D deficiency (CLN10)
Fritchie, K., Siintola, E., Armao, D. M., Lehesjoki, A., Marino, T., Powell, C. M., Tennison, M. B., Booker, J., Koch, S., Partanen, S., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0426-7 · Cited by 79
Self-citationImpaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant
Schulz, A., Dhar, S., Rylova, S. N., Dbaibo, G. S., Alroy, J., Hagel, C., Artacho, I., Kohlschütter, A., Lin, S. M., & Boustany, R. (2004) · Annals of Neurology · doi:10.1002/ana.20187 · Cited by 79
Aiello, C., Terracciano, A., Simonati, A., Discepoli, G., Cannelli, N., Claps, D., Crow, Y. J., Bianchi, M., Kitzmüller, C., Longo, D., et al. (2009) · Human Mutation · doi:10.1002/humu.20975 · Cited by 77
Self-citationBiosynthesis, Glycosylation, and Enzymatic Processingin Vivo of Human Tripeptidyl-peptidase I
Golabek, A. A., Kida, E., Walus, M., Wújek, P., Mehta, P. D., & Wisniewski, K. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211872200 · Cited by 75
CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL
Xin, W., Mullen, T. E., Kiely, R., Min, J., Feng, X., Cao, Y., O'Malley, L., Shen, Y., Chu, C. J., Mole, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cff70d · Cited by 74
Self-citationHolmberg, V., Jalanko, A., Isosomppi, J., Fabritius, A., Peltonen, L., & Kopra, O. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.019 · Cited by 73
Neuronal ceroid lipofuscinoses in childhood
Lauronen, L., Kirveskari, E., Åberg, L. E., Sainio, K., Autti, T. H., & Santavuori, P. (2000) · Neurological Sciences · doi:10.1007/s100720070038 · Cited by 73
Sleat, D. E., Sohár, I., Gin, R. M., & Lobel, P. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0436 · Cited by 67
Storch, S., Pohl, S., & Braulke, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410930200 · Cited by 67
AP-1 and AP-3 Facilitate Lysosomal Targeting of Batten Disease Protein CLN3 via Its Dileucine Motif
Kyttälä, A., Uusi-Rauva, K., Schu, P. V., Jalanko, A., & Luzio, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411862200 · Cited by 67
Ezaki, J., Takeda‐Ezaki, M., Oda, K., & Kominami, E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2207 · Cited by 65
Das, A. K., Lu, J. Y., & Hofmann, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.13.1431 · Cited by 63
Histopathologic and immunocytochemical analysis of the retina and ocular tissues in batten disease
Bensaoula, T., Shibuya, H., Katz, M. L., Smith, J. E., Johnson, G. S., John, S. K., & Milam, A. H. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00264-5 · Cited by 62
Vantaggiato, C., Redaelli, F. C., Falcone, S., Perrotta, C., Tonelli, A., Bondioni, S., Morbin, M., Riva, D., Saletti, V., Bonaglia, M. C., et al. (2009) · Human Mutation · doi:10.1002/humu.21012 · Cited by 61
Nijssen, P. C. G., Ceuterick, C., van Diggelen, O. P., Elleder, M., Martin, J., Teepen, J. L. J. M., Tyynelä, J., & Roos, R. A. C. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00486.x · Cited by 60
Sharifi, A., Kousi, M., Sagné, C., Bellenchi, G. C., Morel, L. J., Darmon, M. C., Hůlková, H., Ruivo, R., Debacker, C., Mestikawy, S. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq381 · Cited by 60
Self-citationLyly, A., von Schantz, C., Salonen, T., Kopra, O., Saarela, J., Jauhiainen, M., Kyttälä, A., & Jalanko, A. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-22 · Cited by 58
A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset
Pineda-Trujillo, N., Cornejo, W., Carrizosa, J., Wheeler, R. B., Munera, S. M. M., Valencia, A., Agudelo-Arango, J., Cogollo, A., Anderson, G. W., Bedoya, G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000151974.44980.f1 · Cited by 57
Self-citationAdult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1
Ramadan, H. M., Al-Din, A. S. N., Ismail, A., Balen, F., Varma, A., Twomey, A., Watts, R., Jackson, M., Anderson, G. W., Green, E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000252825.85947.2f · Cited by 57
Self-citationCompound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis
Wisniewski, K. E., Zhong, N. A., Kaczmarski, W., Kaczmarski, A. L., Kida, E., Brown, W. T., Schwarz, K., Lazzarini, A. M., Rubin, A. J., Stenroos, E. S., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430118 · Cited by 55
Brown, N. J., Corner, B., & Dodgson, M. C. H. (1954) · Archives of Disease in Childhood · doi:10.1136/adc.29.143.48 · Cited by 55
Cannelli, N., Cassandrini, D., Bertini, E., Striano, P., Fusco, L., Gaggero, R., Specchio, N., Biancheri, R., Vigevano, F., Bruno, C., et al. (2006) · Neurogenetics · doi:10.1007/s10048-005-0024-y · Cited by 54
Steenhuis, P., Herder, S., Gelis, S., Braulke, T., & Storch, S. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01073.x · Cited by 53
Congenital ceroid-lipofuscinosis
Barohn, R. J., Dowd, D. C., & Kagan‐Hallet, K. S. (1992) · Pediatric Neurology · doi:10.1016/0887-8994(92)90054-3 · Cited by 53
Sleat, D. E., Ding, L., Wang, S., Zhao, C., Wang, Y., Xin, W. W., Zheng, H., Moore, D. F., & Sims, K. B. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900122-mcp200 · Cited by 53
Nijssen, P. C. G., Brusse, E., Leyten, A. C. M., Martin, J., Teepen, J. L. J. M., & Roos, R. A. C. (2002) · Movement Disorders · doi:10.1002/mds.10104 · Cited by 53
Lebrun, A.-H., Storch, S., Rüschendorf, F., Schmiedt, M.-L., Kyttälä, A., Mole, S., Kitzmüller, C., Saar, K., Mewasingh, L., Boda, V., et al. (2009) · Human Mutation · doi:10.1002/humu.21010 · Cited by 52
Self-citationSchmiedt, M.-L., Bessa, C., Heine, C., Ribeiro, M. G., Jalanko, A., & Kyttälä, A. (2010) · Human Mutation · doi:10.1002/humu.21195 · Cited by 52
Storch, S., Pohl, S., Quitsch, A., Falley, K., & Braulke, T. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00537.x · Cited by 51
Heine, C., Heine, C., Quitsch, A., Storch, S., Hewings-Martin, Y., Lonka, L., Lehesjoki, A., Mole, S., & Braulke, T. (2007) · Molecular Membrane Biology · doi:10.1080/09687860600967317 · Cited by 50
Self-citationScarborough, P. E., & Dunn, B. M. (1994) · Protein Engineering Design and Selection · doi:10.1093/protein/7.4.495 · Cited by 49
Lonka, L., Salonen, T., Siintola, E., Kopra, O., Lehesjoki, A., & Jalanko, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20133 · Cited by 47
Self-citationGenomic Structure and Complete Nucleotide Sequence of the Batten Disease Gene,CLN3
Mitchison, H. M., Munroe, P. B., O'Rawe, A., Taschner, P. E. M., de Vos, N., Kremmidiotis, G., Lensink, I. L., Munk, A. C., D'Arigo, K. L., Anderson, J. W., et al. (1997) · Genomics · doi:10.1006/geno.1996.4576 · Cited by 46
Self-citationNeuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common theme emerging
Aldahmesh, M. A., Al‐Hassnan, Z. N., Aldosari, M., & Alkuraya, F. S. (2009) · Neurogenetics · doi:10.1007/s10048-009-0185-1 · Cited by 46
Revelation of a Novel CLN5 Mutation in Early Juvenile Neuronal Ceroid Lipofuscinosis
Cannelli, N., Nardocci, N., Cassandrini, D., Morbin, M., Aiello, C., Bugiani, M., Criscuolo, L., Zara, F., Striano, P., Granata, T., et al. (2007) · Neuropediatrics · doi:10.1055/s-2007-981449 · Cited by 46
Nugent, T. S., Mole, S., & Jones, D. T. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.049 · Cited by 45
Self-citationVariant late infantile ceroid lipofuscinoses associated with novel mutations in CLN6
Cannelli, N., Garavaglia, B., Simonati, A., Aiello, C., Barzaghi, C., Pezzini, F., Cilio, M. R., Biancheri, R., Morbin, M., Bernardina, B. D., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.159 · Cited by 44
Self-citationReinhardt, K., Grapp, M., Schlachter, K., Brück, W., Gärtner, J., & Steinfeld, R. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01285.x · Cited by 42
Teixeira, C. A., Guimar�es, A., Bessa, C., Ferreira, M. J., Lopes, L., Pinto, E., Pinto, R., Boustany, R., Sá-Miranda, C., & Ribeiro, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1050-z · Cited by 41
A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis
Stögmann, E., Tawil, S. E., Wagenstaller, J., Gaber, A., Edris, S., Abdelhady, A., Assem‐Hilger, E., Leutmezer, F., Bonelli, S. B., Baumgärtner, C., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0153-1 · Cited by 39
Elleder, M., Dvořáková, L., Stolnaja, L., Vlášková, H., Hůlková, H., Druga, R., Poupětová, H., Košťálová, E., & Mikuláštík, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0349-3 · Cited by 39
Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipoluscinosis
Zhong, N., Krystyna, Wisniewski, É., Hartikainen, J. M., Ju, W., Moroziewicz, D. N., McLendon, L., Brooks, S. S., & Brown, W. T. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb04291.x · Cited by 38
Kufs disease: Clinical features and forms
Berkovic, S. F., Andermann, F., Andermann, E., Carpenter, S., Wolfe, L., Opitz, J. M., Reynolds, J. F., & Pullarkat, R. K. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320310614 · Cited by 38
Heterogeneity of late-infantile neuronal ceroid lipofuscinosis
Zhong, N., Moroziewicz, D. N., Ju, W., Jurkiewicz, A., Johnston, L., Wisniewski, K. E., & Brown, W. T. (2000) · Genetics in Medicine · doi:10.1097/00125817-200011000-00002 · Cited by 38
Bessa, C., Teixeira, C. A., Mangas, M., Dias, A., Sá-Miranda, C., Guimarães, A., Ferreira, J. C., Canas, N., Cabral, P., & Ribeiro, G. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.04.010 · Cited by 37
Elleder, M., Franc, J., Kraus, J., Nevšímalová, S., Sixtová, K., & Zeman, J. (1997) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(97)80041-4 · Cited by 35
Zhong, N., Wisniewski, K. E., Kaczmarski, A. L., Ju, W., Xu, W. M., Xu, W. W., Mclendon, L., Liu, B., Kaczmarski, W., Brooks, S. S., et al. (1998) · Human Genetics · doi:10.1007/s004390050654 · Cited by 34
Adams, H., Beck, C. A., Levy, E., Jordan, R., Kwon, J. M., Marshall, F. J., Vierhile, A., Augustine, E. F., de Blieck, E. A., Pearce, D. A., et al. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03628.x · Cited by 34
Bessa, C., Teixeira, C. A., Dias, A., Alves, M., Rocha, S., Lacerda, L., Loureiro, L., Guimarães, A., & Ribeiro, G. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.08.124 · Cited by 33
CONGENITAL AMAUROTIC IDIOCY ‐A PATHOLOGICAL, HISTOCHEMICAL, BIOCHEMICAL AND ULTRASTRUCTURAL STUDY
Humphreys, S., Lake, B. D., & Scholtz, C. L. (1985) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1985.tb00041.x · Cited by 33
Late Infantile Neuronal Ceroid Lipofuscinosis Is Due to Splicing Mutations in the CLN2 Gene
Hartikainen, J. M., Ju, W., Wisniewski, K. E., Moroziewicz, D. N., Kaczmarski, A. L., McLendon, L., Zhong, D., Suarez, C. T., Brown, W. T., & Zhong, N. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2853 · Cited by 32
Palmitoyl-Protein thioesterase deficiency in a novel granular variant of LINCL
Wisniewski, K. E., Connell, F., Kaczmarski, W., Kaczmarski, A. L., Siakotos, A. N., Becerra, C. R., & Hofmann, S. L. (1998) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00173-2 · Cited by 32
Siintola, E., Topçu, M., Kohlschütter, A., Salonen, T., Joensuu, T. H., Anttonen, A.-K., & Lehesjoki, A. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00471.x · Cited by 30
Self-citationProtracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X)
Sarpong, A., Schottmann, G., Rüther, K., Stoltenburg, G., Kohlschütter, A., Hübner, C., & Schuelke, M. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01179.x · Cited by 30
Steinfeld, R., Steinke, H.-B., Isbrandt, D., Kohlschütter, A., & Gärtner, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh264 · Cited by 30
Characterizing pathogenic processes in Batten disease: Use of small eukaryotic model systems
Phillips, S. N., Muzaffar, N. E., Codlin, S., Korey, C. A., Taschner, P. E. M., de Voer, G., Mole, S., & Pearce, D. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.08.010 · Cited by 28
Self-citationWaliany, S., Das, A. K., Gaben, A., Wisniewski, K. E., & Hofmann, S. L. (2000) · Human Mutation · Cited by 28
Kurze, A.-K., Galliciotti, G., Heine, C., Mole, S., Quitsch, A., & Braulke, T. (2009) · Human Mutation · doi:10.1002/humu.21184 · Cited by 27
Self-citationCONGENITAL NEURONAL CEROID LIPOFUSCINOSIS A Case Report
GARBORG, I., TORVIK, A., Hals, J., Tangsrud, S. E., & Lindemann, R. (1987) · Acta Pathologica Microbiologica Scandinavica Series A Pathology · doi:10.1111/j.1699-0463.1987.tb00017_95a.x · Cited by 24
Sandbank, U. (1968) · PubMed · Cited by 24
Santavuori, P., Rapola, J., Raininko, R., Autti, T. H., Lappi, M., Nuutila, A., Launes, J., & Sainio, K. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710251 · Cited by 23
Profound Infantile Neuroretinal Dysfunction in a Heterozygote for the CLN3 Genetic Defect
Reyes, E. D. L., Dyken, P. R., Phillips, P. H., et al. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190010703 · Cited by 21
Late onset juvenile neuronal ceroid‐lipofuscinosis with granular osmiophilic deposits (GROD)
Hofman, I. L., & Taschner, P. E. M. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320570211 · Cited by 21
Åberg, L. E., Lauronen, L., Hämäläinen, J., Mole, S., & Autti, T. H. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.10.012 · Cited by 19
Self-citationKälviäinen, R. K., Eriksson, K. J., Losekoot, M., Sorri, I., Harvima, I. T., Santavuori, P., Järvelä, I. E., Autti, T. H., Vanninen, R., Salmenpera, T. M., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01668.x · Cited by 17
Gene expression profiling in vLINCL CLN6-deficient fibroblasts: Insights into pathobiology
Teixeira, C. A., Lin, S. M., Mangas, M., Quinta, R., Bessa, C., Ferreira, C., Sá-Miranda, C., Boustany, R., & Ribeiro, G. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.002 · Cited by 16
Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis
Bonsignore, M. R., Tessa, A., Rosa, G. D., Piemonte, F., Dionisi‐Vici, C., Simonati, A., Calamoneri, F., Tortorella, G., & Santorelli, F. M. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.04.002 · Cited by 15
Lin, L., & Lobel, P. (2001) · Human Mutation · doi:10.1002/humu.1170 · Cited by 14
Strategy for Mutation Detection in CLN3: Characterisation of Two Finnish Mutations
Munroe, P. B., O'Rawe, A., Mitchison, H. M., Järvelä, I. E., Santavuori, P., Lerner, T. J., Taschner, P. E. M., Gardiner, R. M., & Mole, S. (1997) · Neuropediatrics · doi:10.1055/s-2007-973657 · Cited by 11
Self-citationKwon, J. M., Rothberg, P. G., Leman, A. R., Weimer, J. M., Mink, J. W., & Pearce, D. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.023 · Cited by 11
Gene symbol: CLN5. Disease: Neuronal Ceroid Lipofuscinosis, Finnish Variant.
Kohan, R., Cannelli, N., Aiello, C., Santorelli, F. M., Cismondi, A. I., Milà, M., Ramírez, A. M. O., & Halac, I. N. (2008) · PubMed · Cited by 7
Cited by
Lysosomal cathepsins and their regulation in aging and neurodegeneration
Stoka, V., Turk, V., & Turk, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.010 · Cited by 334
Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
Mole, S. E., & Cotman, S. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.011 · Cited by 331
Self-citationNCL diseases - clinical perspectives
Schulz, A., Kohlschütter, A., Mink, J., Simonati, A., & Williams, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.008 · Cited by 246
Nickel, M., Simonati, A., Jacoby, D., Lezius, S., Kilian, D., Van de Graaf, B., Pagovich, O. E., Kosofsky, B., Yohay, K., Downs, M., et al. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30179-2 · Cited by 148
Sondhi, D., Kaminsky, S. M., Hackett, N. R., Pagovich, O. E., Rosenberg, J. B., De, B. P., Chen, A., Van de Graaf, B., Mezey, J. G., Mammen, G. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5413 · Cited by 72
Metadata
- Authors
- Kousi, M., Lehesjoki, A.-E., & Mole, S. E.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2011-11-16
- Volume
- 33
- Issue
- 1
- Pages
- 42-63
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2078557934
- Cited by
- 332
- References
- 145
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.